Arena Pharmaceuticals Inc (ARNA.OQ)

ARNA.OQ on NASDAQ Stock Exchange Global Select Market

3.90USD
17 Sep 2014
Price Change (% chg)

$-0.02 (-0.51%)
Prev Close
$3.92
Open
$3.93
Day's High
$3.98
Day's Low
$3.89
Volume
494,024
Avg. Vol
1,151,515
52-wk High
$7.97
52-wk Low
$3.83

ARNA.OQ

Chart for ARNA.OQ

About

Arena Pharmaceuticals, Inc. (Arena) is a biopharmaceutical company focused on discovering, developing and commercializing drugs that target G protein-coupled receptors. Its wholly owned subsidiary, Arena Pharmaceuticals GmbH (Arena GmbH), has granted Eisai Inc., rights to commercialize BELVIQ in the United States. The Company’s... (more)

Overall

Beta: -0.32
Market Cap (Mil.): $857.36
Shares Outstanding (Mil.): 219.84
Dividend: --
Yield (%): --

Financials

  ARNA.OQ Industry Sector
P/E (TTM): -- 146.41 33.29
EPS (TTM): -0.27 -- --
ROI: -22.27 -3.28 17.33
ROE: -51.31 -7.94 18.19
Search Stocks

Competitors

  Price Change
Novo Nordisk A/S (NOVOb.CO) kr.281.35 +4.05
Roche Holding Ltd. (ROG.VX) CHF282.90 +2.10
GlaxoSmithKline plc (GSK.L) 1,439.00p +5.00
VIVUS, Inc. (VVUS.OQ) $3.88 +0.10
Orexigen Therapeutics, Inc. (OREX.OQ) $4.96 +0.18

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: S&P Capital IQ Quantitative Report
$127.00
Provider: Pechala's Reports
$25.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks